{
    "clinical_study": {
        "@rank": "72305", 
        "arm_group": {
            "arm_group_label": "Specimen Collection"
        }, 
        "biospec_descr": {
            "textblock": "Leftover urine samples"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "To evaluate the illumigene Chlamydia and illumigene Gonorrhea assays, using the\n      illumipro-10, with  male urine, female urine, physician-collected (medical professional)\n      endocervical swabs and self-collected vaginal swabs taken from symptomatic and asymptomatic\n      patient populations."
        }, 
        "brief_title": "Detection of Chlamydia (CT) and Gonorrhea (NG)", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chlamydia", 
            "Gonorrhea"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Chlamydia Infections", 
                "Gonorrhea"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male or female\n\n          2. Any ethnicity or race\n\n          3. Subject >14 and <89 years of age\n\n          4. Subject who voluntarily gives written informed consent\n\n          5. Symptomatic or asymptomatic subject who is able and willing to provide the required\n             urine and swab samples for testing for CT and NG\n\n        Exclusion Criteria:\n\n          1. Subjects < 14 or >90 years of age\n\n          2. Subjects who are unwilling to sign the written informed consent\n\n          3. Subject who is unwilling or unable to provide the required urine and swab samples for\n             testing\n\n          4. Individuals who have been on antibiotic medications within 10 days.\n\n          5. Multiple sets of specimens from the same subject at different office visits\n\n          6. Samples collected or processed in manner other than specified in the study protocol\n             and Investigational Use Only package insert.\n\n          7. Frozen archived specimens"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "89 Years", 
            "minimum_age": "14 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Symptomatic and asymptomatic subjects at least 14 years of age"
            }
        }, 
        "enrollment": {
            "#text": "6600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02055742", 
            "org_study_id": "MBI-01-CTNG", 
            "secondary_id": "Meridian Bioscience, Inc."
        }, 
        "intervention": {
            "arm_group_label": "Specimen Collection", 
            "intervention_name": "illumigene CT and NG assays, illumipro-10", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 27, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Mark Bergeron", 
                    "phone": "508-672-7450"
                }, 
                "facility": {
                    "address": {
                        "city": "Fall River", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02720"
                    }, 
                    "name": "New England Center for Clinical Research"
                }, 
                "investigator": {
                    "last_name": "Stephen Kasperian, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "illona.feldman@ppsp.org", 
                    "last_name": "Illona Feldman, MA", 
                    "phone": "267-514-2098"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Planned Parenthood Southeastern PA"
                }, 
                "investigator": {
                    "last_name": "Joel Lebed, D.O.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Clinical Study Protocol for the Illumigene\u00ae Chlamydia and Illumigene\u00ae Gonorrhea DNA Amplification Assays", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Testing of each set of subject samples is completed within 60 days of sample collection", 
            "measure": "Qualitative detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease", 
            "safety_issue": "No", 
            "time_frame": "Up to 60 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02055742"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Meridian Bioscience, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meridian Bioscience, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}